{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:40:53Z","timestamp":1792176053935,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite having common overlapping immunophenotypic and morphological features, T-cell lymphoblastic leukemia (T-ALL) and lymphoma (T-LBL) have distinct clinical manifestations, which may represent separate diseases. We investigated and compared the epigenetic and genetic landscape of adult and pediatric T-ALL (<jats:italic>n<\/jats:italic>\u2009=\u200977) and T-LBL (<jats:italic>n<\/jats:italic>\u2009=\u200915) patient samples by high-resolution genome-wide DNA methylation and Copy Number Variation (CNV) BeadChip arrays. DNA methylation profiling identified the presence of CpG island methylator phenotype (CIMP) subgroups within both pediatric and adult T-LBL and T-ALL. An epigenetic signature of 128 differentially methylated CpG sites was identified, that clustered T-LBL and T-ALL separately. The most significant differentially methylated gene loci included the <jats:italic>SGCE\/PEG10<\/jats:italic> shared promoter region, previously implicated in lymphoid malignancies. CNV analysis confirmed overlapping recurrent aberrations between T-ALL and T-LBL, including 9p21.3 (<jats:italic>CDKN2A\/CDKN2B<\/jats:italic>) deletions. A significantly higher frequency of chromosome 13q14.2 deletions was identified in T-LBL samples (36% in T-LBL vs. 0% in T-ALL). This deletion, encompassing the <jats:italic>RB1, MIR15A<\/jats:italic> and <jats:italic>MIR16-1<\/jats:italic> gene loci, has been reported as a recurrent deletion in B-cell malignancies. Our study reveals epigenetic and genetic markers that can distinguish between T-LBL and T-ALL, and deepen the understanding of the biology underlying the diverse disease localization.<\/jats:p>","DOI":"10.1038\/s41408-020-0310-9","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T14:03:58Z","timestamp":1588082638000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["DNA methylation and copy number variation profiling of T-cell lymphoblastic leukemia and lymphoma"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0759-3932","authenticated-orcid":false,"given":"Zahra","family":"Haider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Landfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8741-0616","authenticated-orcid":false,"given":"Irina","family":"Golovleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Erlanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjeld","family":"Schmiegelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trond","family":"Fl\u00e6gstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Kanerva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika","family":"Nor\u00e9n-Nystr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Hultdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2783-0712","authenticated-orcid":false,"given":"Sofie","family":"Degerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,28]]},"reference":[{"key":"310_CR1","unstructured":"Swerdlow, S. H. et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Revised 4th edn. (International Agency for Research on Cancer, France, 2017)."},{"key":"310_CR2","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1200\/JCO.2005.02.2707","volume":"24","author":"B Burkhardt","year":"2006","unstructured":"Burkhardt, B. et al. Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma. J. Clin. Oncol. 24, 491\u20139 (2006).","journal-title":"J. Clin. Oncol."},{"key":"310_CR3","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1182\/blood-2012-12-474148","volume":"121","author":"BR Bonn","year":"2013","unstructured":"Bonn, B. R. et al. Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence. Blood. 121, 3153\u201360 (2013).","journal-title":"Blood."},{"key":"310_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/pbc.20550","volume":"47","author":"EA Raetz","year":"2006","unstructured":"Raetz, E. A. et al. Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Pediatric Blood Cancer 47, 130\u201340 (2006).","journal-title":"Pediatric Blood Cancer"},{"key":"310_CR5","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/gcc.20924","volume":"50","author":"K Basso","year":"2011","unstructured":"Basso, K. et al. T-cell lymphoblastic lymphoma shows differences and similarities with T-cell acute lymphoblastic leukemia by genomic and gene expression analyses. Genes Chromosomes Cancer 50, 1063\u201375 (2011).","journal-title":"Genes Chromosomes Cancer"},{"key":"310_CR6","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1002\/pbc.25958","volume":"63","author":"M Borssen","year":"2016","unstructured":"Borssen, M. et al. DNA methylation adds prognostic value to minimal residual disease status in pediatric T-cell acute lymphoblastic leukemia. Pediatric Blood Cancer 63, 1185\u201392 (2016).","journal-title":"Pediatric Blood Cancer"},{"key":"310_CR7","doi-asserted-by":"publisher","first-page":"e65373","DOI":"10.1371\/journal.pone.0065373","volume":"8","author":"M Borssen","year":"2013","unstructured":"Borssen, M. et al. Promoter DNA methylation pattern identifies prognostic subgroups in childhood T-cell acute lymphoblastic leukemia. PLoS ONE. 8, e65373 (2013).","journal-title":"PLoS ONE."},{"key":"310_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-9-r105","volume":"14","author":"J Nordlund","year":"2013","unstructured":"Nordlund, J. et al. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia. Genome Biol. 14, r105 (2013).","journal-title":"Genome Biol."},{"key":"310_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/cam4.1917","volume":"8","author":"Z Haider","year":"2019","unstructured":"Haider, Z. et al. An integrated transcriptome analysis in T-cell acute lymphoblastic leukemia links DNA methylation subgroups to dysregulated TAL1 and ANTP homeobox gene expression. Cancer Med. 8, 311\u201324 (2019).","journal-title":"Cancer Med."},{"key":"310_CR10","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber, D. A. et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 127, 2391\u2013405 (2016).","journal-title":"Blood."},{"key":"310_CR11","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"Cancer Genome Atlas Research N","year":"2013","unstructured":"Cancer Genome Atlas Research N et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 368, 2059\u201374 (2013).","journal-title":"N. Engl. J. Med."},{"key":"310_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-4-r54","volume":"15","author":"K Lokk","year":"2014","unstructured":"Lokk, K. et al. DNA methylome profiling of human tissues identifies global and tissue-specific methylation patterns. Genome Biol. 15, r54 (2014).","journal-title":"Genome Biol."},{"key":"310_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/bioinformatics\/bts680","volume":"29","author":"AE Teschendorff","year":"2013","unstructured":"Teschendorff, A. E. et al. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics. 29, 189\u201396 (2013).","journal-title":"Bioinformatics."},{"key":"310_CR14","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1093\/bioinformatics\/btx513","volume":"33","author":"Y Tian","year":"2017","unstructured":"Tian, Y. et al. ChAMP: updated methylation analysis pipeline for Illumina BeadChips. Bioinformatics. 33, 3982\u20134 (2017).","journal-title":"Bioinformatics."},{"key":"310_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-10-r115","volume":"14","author":"S Horvath","year":"2013","unstructured":"Horvath, S. DNA methylation age of human tissues and cell types. Genome Biol. 14, R115 (2013).","journal-title":"Genome Biol."},{"key":"310_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1064-3","volume":"17","author":"Z Yang","year":"2016","unstructured":"Yang, Z. et al. Correlation of an epigenetic mitotic clock with cancer risk. Genome Biol. 17, 205 (2016).","journal-title":"Genome Biol."},{"key":"310_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357 (2009).","journal-title":"Nat. Protoc."},{"key":"310_CR18","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee, M. J. et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 30, 1363\u20139 (2014).","journal-title":"Bioinformatics."},{"key":"310_CR19","unstructured":"Hovestadt, V. & Zapatka, M. Conumee: enhanced copy-number variation analysis using Illumina DNA methylation arrays. R package version 1.9.0 (2017)."},{"key":"310_CR20","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3324\/haematol.2009.011114","volume":"95","author":"R Okamoto","year":"2010","unstructured":"Okamoto, R. et al. Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia. Haematologica. 95, 1481\u20138 (2010).","journal-title":"Haematologica."},{"key":"310_CR21","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/ng.3909","volume":"49","author":"Y Liu","year":"2017","unstructured":"Liu, Y. et al. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat. Genet. 49, 1211\u20131218 (2017).","journal-title":"Nat. Genet."},{"key":"310_CR22","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1002\/ijc.22929","volume":"121","author":"B Kainz","year":"2007","unstructured":"Kainz, B. et al. Overexpression of the paternally expressed gene 10 (PEG10) from the imprinted locus on chromosome 7q21 in high-risk B-cell chronic lymphocytic leukemia. Int. J. Cancer 121, 1984\u201393 (2007).","journal-title":"Int. J. Cancer"},{"key":"310_CR23","doi-asserted-by":"publisher","first-page":"4272","DOI":"10.1016\/j.febslet.2007.07.074","volume":"581","author":"T Hishida","year":"2007","unstructured":"Hishida, T., Naito, K., Osada, S., Nishizuka, M. & Imagawa, M. peg10, an imprinted gene, plays a crucial role in adipocyte differentiation. FEBS Lett. 581, 4272\u20138 (2007).","journal-title":"FEBS Lett."},{"key":"310_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-018-0610-3","volume":"18","author":"T Xie","year":"2018","unstructured":"Xie, T. et al. PEG10 as an oncogene: expression regulatory mechanisms and role in tumor progression. Cancer Cell Int. 18, 112 (2018).","journal-title":"Cancer Cell Int."},{"key":"310_CR25","doi-asserted-by":"publisher","first-page":"844","DOI":"10.4143\/crt.2014.124","volume":"47","author":"H Bang","year":"2015","unstructured":"Bang, H., Ha, S. Y., Hwang, S. H. & Park, C. K. Expression of PEG10 is associated with poor survival and tumor recurrence in hepatocellular carcinoma. Cancer Res. Treat. 47, 844\u201352 (2015).","journal-title":"Cancer Res. Treat."},{"key":"310_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13046-017-0500-x","volume":"36","author":"YP Peng","year":"2017","unstructured":"Peng, Y. P. et al. PEG10 overexpression induced by E2F-1 promotes cell proliferation, migration, and invasion in pancreatic cancer. J. Exp. Clin. Cancer Res. 36, 30 (2017).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"310_CR27","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1158\/0008-5472.CAN-05-1553","volume":"66","author":"CM Li","year":"2006","unstructured":"Li, C. M. et al. PEG10 is a c-MYC target gene in cancer cells. Cancer Res. 66, 665\u201372 (2006).","journal-title":"Cancer Res."},{"key":"310_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cca.2018.04.041","volume":"483","author":"H Ge","year":"2018","unstructured":"Ge, H., Yan, Y., Wu, D., Huang, Y. & Tian, F. Prognostic value of PEG10 in Asian solid tumors: a meta-analysis. Clin. Chim. Acta 483, 197\u2013203 (2018).","journal-title":"Clin. Chim. Acta"},{"key":"310_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10238-015-0350-9","volume":"16","author":"W Peng","year":"2016","unstructured":"Peng, W., Fan, H., Wu, G., Wu, J. & Feng, J. Upregulation of long noncoding RNA PEG10 associates with poor prognosis in diffuse large B cell lymphoma with facilitating tumorigenicity. Clin. Exp. Med. 16, 177\u201382 (2016).","journal-title":"Clin. Exp. Med."},{"key":"310_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergencyto.2006.07.011","volume":"172","author":"MA Lones","year":"2007","unstructured":"Lones, M. A. et al. Chromosome abnormalities in advanced stage lymphoblastic lymphoma of children and adolescents: a report from CCG-E08. Cancer Genet. Cytogenet. 172, 1\u201311 (2007).","journal-title":"Cancer Genet. Cytogenet."},{"key":"310_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cancergencyto.2009.01.002","volume":"191","author":"M Schraders","year":"2009","unstructured":"Schraders, M. et al. High-resolution genomic profiling of pediatric lymphoblastic lymphomas reveals subtle differences with pediatric acute lymphoblastic leukemias in the B-lineage. Cancer Genet. Cytogenet. 191, 27\u201333 (2009).","journal-title":"Cancer Genet. Cytogenet."},{"key":"310_CR32","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.ejca.2008.02.011","volume":"44","author":"A Uyttebroeck","year":"2008","unstructured":"Uyttebroeck, A. et al. Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: long term results of the EORTC CLG 58881 trial. Eur. J. Cancer 44, 840\u20136 (2008).","journal-title":"Eur. J. Cancer"},{"key":"310_CR33","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/j.1365-2141.2011.08788.x","volume":"154","author":"M Sekimizu","year":"2011","unstructured":"Sekimizu, M. et al. Chromosome abnormalities in advanced stage T-cell lymphoblastic lymphoma of children and adolescents: a report from Japanese Paediatric Leukaemia\/Lymphoma Study Group (JPLSG) and review of the literature. Br. J. Haematol. 154, 612\u20137 (2011).","journal-title":"Br. J. Haematol."},{"key":"310_CR34","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/hon.2032","volume":"31","author":"EM Orlandi","year":"2013","unstructured":"Orlandi, E. M. et al. Chronic lymphocytic leukemia with del13q14 as the sole abnormality: dynamic prognostic estimate by interphase-FISH. Hematol. Oncol. 31, 136\u201342 (2013).","journal-title":"Hematol. Oncol."},{"key":"310_CR35","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s12185-017-2240-2","volume":"106","author":"S Yi","year":"2017","unstructured":"Yi, S. et al. The prognostic significance of 13q deletions of different sizes in patients with B-cell chronic lymphoproliferative disorders: a retrospective study. Int. J. Hematol. 106, 418\u201325 (2017).","journal-title":"Int. J. Hematol."},{"key":"310_CR36","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1182\/blood-2009-10-249367","volume":"115","author":"A Palamarchuk","year":"2010","unstructured":"Palamarchuk, A. et al. 13q14 deletions in CLL involve cooperating tumor suppressors. Blood. 115, 3916\u201322 (2010).","journal-title":"Blood."},{"key":"310_CR37","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1200\/JCO.2000.18.22.3837","volume":"18","author":"NA Heerema","year":"2000","unstructured":"Heerema, N. A. et al. Abnormalities of chromosome bands 13q12 to 13q14 in childhood acute lymphoblastic leukemia. J. Clin. Oncol. 18, 3837\u201344 (2000).","journal-title":"J. Clin. Oncol."},{"key":"310_CR38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cancergencyto.2003.09.022","volume":"151","author":"BZ Kovacs","year":"2004","unstructured":"Kovacs, B. Z., Niggli, F. K. & Betts, D. R. Aberrations involving 13q12 approximately q14 are frequent secondary events in childhood acute lymphoblastic leukemia. Cancer Genet. Cytogenet. 151, 157\u201361 (2004).","journal-title":"Cancer Genet. Cytogenet."},{"key":"310_CR39","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1470-2045(10)70066-8","volume":"11","author":"AV Moorman","year":"2010","unstructured":"Moorman, A. V. et al. Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97\/99 randomised trial. Lancet Oncol. 11, 429\u201338 (2010).","journal-title":"Lancet Oncol."},{"key":"310_CR40","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/sj.leu.2402849","volume":"17","author":"L Harewood","year":"2003","unstructured":"Harewood, L. et al. Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases. Leukemia. 17, 547\u201353 (2003).","journal-title":"Leukemia."},{"key":"310_CR41","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/bjh.13043","volume":"167","author":"K Lin","year":"2014","unstructured":"Lin, K. et al. Loss of MIR15A and MIR16-1 at 13q14 is associated with increased TP53 mRNA, de-repression of BCL2 and adverse outcome in chronic lymphocytic leukaemia. Br. J. Haematol. 167, 346\u201355 (2014).","journal-title":"Br. J. Haematol."},{"key":"310_CR42","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ccr.2010.09.009","volume":"18","author":"H Feng","year":"2010","unstructured":"Feng, H. et al. T-lymphoblastic lymphoma cells express high levels of BCL2, S1P1, and ICAM1, leading to a blockade of tumor cell intravasation. Cancer Cell. 18, 353\u201366 (2010).","journal-title":"Cancer Cell."},{"key":"310_CR43","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1513257","volume":"374","author":"AW Roberts","year":"2016","unstructured":"Roberts, A. W. et al. Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia. N. Engl. J. Med. 374, 311\u201322 (2016).","journal-title":"N. Engl. J. Med."},{"key":"310_CR44","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1158\/2159-8290.CD-16-0313","volume":"6","author":"M Konopleva","year":"2016","unstructured":"Konopleva, M. et al. Efficacy and biological correlates of response in a phase II study of venetoclax monotherapy in patients with acute myelogenous leukemia. Cancer Discov. 6, 1106\u201317 (2016).","journal-title":"Cancer Discov."}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-020-0310-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-020-0310-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-020-0310-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T14:27:02Z","timestamp":1670250422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-020-0310-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,28]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4]]}},"alternative-id":["310"],"URL":"https:\/\/doi.org\/10.1038\/s41408-020-0310-9","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,28]]},"assertion":[{"value":"23 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"45"}}